Home
University of Bergen
Indu Dhar's picture

Indu Dhar

Researcher
Department of Clinical Science
  • E-mailindu.dhar@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). Association between dietary macronutrient composition and plasma one-carbon metabolites and B-vitamin cofactors in patients with stable angina pectoris. British Journal of Nutrition.
  • Show author(s) (2023). Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2-cohort study. Journal of Internal Medicine. 508-519.
  • Show author(s) (2023). B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study. American Journal of Clinical Nutrition. 77-84.
  • Show author(s) (2022). Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment. International Journal of Cardiology: Cardiovascular Risk and Prevention (IJCCRP). 6 pages.
  • Show author(s) (2022). Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease. Journal of Internal Medicine. 915-924.
  • Show author(s) (2021). β-blocker use and risk of all-cause mortality in patients with coronary heart disease: effect modification by serum vitamin A. European Journal of Preventive Cardiology (EJPC). 1897-1902.
  • Show author(s) (2021). Trimethyllysine predicts all-cause and cardiovascular mortality in community-dwelling adults and patients with coronary heart disease. European Heart Journal Open (EHJ Open). 10 pages.
  • Show author(s) (2021). Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts. European Journal of Preventive Cardiology (EJPC). e128-e137.
  • Show author(s) (2020). Transsulfuration metabolites and the association with incident atrial fibrillation – An observational cohort study among Norwegian patients with stable angina pectoris. International Journal of Cardiology. 75-80.
  • Show author(s) (2020). Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin. Heart. 1073-1079.
  • Show author(s) (2020). Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. Journal of Internal Medicine. 446-456.
  • Show author(s) (2019). Elevated plasma cystathionine is associated with increased risk of mortality among patients with suspected or established coronary heart disease. American Journal of Clinical Nutrition. 1546-1554.
  • Show author(s) (2019). Dietary choline is related to increased risk of acute myocardial infarction in patients with stable angina pectoris. Biochimie.
  • Show author(s) (2019). Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. European Heart Journal. 371-380.
  • Show author(s) (2019). Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease. European Journal of Nutrition.
  • Show author(s) (2018). Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial. Journal of Internal Medicine. 232-244.
  • Show author(s) (2018). The risk association of plasma total homocysteine with acute myocardial infarction is modified by serum vitamin A. European Journal of Preventive Cardiology (EJPC). 1612-1620.
  • Show author(s) (2018). Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors. Atherosclerosis. 175-181.
  • Show author(s) (2018). Plasma cystathionine and risk of incident stroke in patients with suspected stable angina pectoris. Journal of the American Heart Association (JAHA). 12 pages.
  • Show author(s) (2018). Plasma cystathionine and risk of acute myocardial infarction among patients with coronary heart disease: Results from two independent cohorts. International Journal of Cardiology. 24-30.
  • Show author(s) (2018). Pharmacological evaluation of novel PKR inhibitor indirubin-3-hydrazone in-vitro in cardiac myocytes and in-vivo in wistar rats. Life Sciences. 85-96.
  • Show author(s) (2018). Inhibition of protein kinase R protects against palmitic acid?induced inflammation, oxidative stress, and apoptosis through the JNK/NF-kB/NLRP3 pathway in cultured H9C2 cardiomyocytes. Journal of Cellular Biochemistry.
  • Show author(s) (2018). Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. International Journal of Cardiology. 7 pages.
  • Show author(s) (2018). Imoxin attenuates high fructose-induced oxidative stress and apoptosis in renal epithelial cells via downregulation of protein kinase R pathway. Fundamental & Clinical Pharmacology. 297-305.
  • Show author(s) (2017). Metabolomic evaluation of the consequences of plasma cystathionine elevation in adults with stable angina pectoris. Journal of Nutrition. 1658-1668.
  • Show author(s) (2017). High glucose impairs insulin signaling via activation of PKR pathway in L6 muscle cells. Biochemical and Biophysical Research Communications - BBRC. 645-651.
  • Show author(s) (2016). Pharmacological evaluation of novel alagebrium analogs as methylglyoxal scavengers in vitro in cardiac myocytes and in vivo in SD rats. International Journal of Cardiology. 581-589.
Academic literature review
  • Show author(s) (2019). SGLT1 inhibition boon or bane for diabetes-associated cardiomyopathy. Fundamental & Clinical Pharmacology. 1-16.

More information in national current research information system (CRIStin)